CLOROX CO /DE/ (CLX) Insider Transactions
Over the last 12 months, 20 CLOROX CO /DE/ (CLX) insiders filed 116 SEC Form 4 transactions — $845.6K in open-market purchases ( 1 distinct buyers) and $1.9M in open-market sales. 0% of all transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.
- $845.6KOpen-market buys (1y)
- $1.9MOpen-market sells (1y)
- 20Distinct insiders
- 116Transactions filed
- 0%Under Rule 10b5-1 plan
- 2026-07-22Latest filing
Recent Form 4 Filings Most recent 50 of 116 (1-year window)
Each row is a single Form 4 filing event for CLX, sourced directly from SEC EDGAR. The Type column classifies the SEC transaction code into Buy / Sell / Grant / Exercise / Other; the 10b5-1 badge marks trades executed under a pre-scheduled SEC Rule 10b5-1 plan.
| Date | Insider | Title | Type | SEC Code | Value | Shares | Price |
|---|---|---|---|---|---|---|---|
| 2026-07-22 | Barton Nina | EVP-Chief Growth & Strategy Of | Other | F | $160.9K | 1,681 | $95.7 |
| 2026-07-15 | Hyder Chris T | EVP-Chief Operating Officer | Other | F | $26.2K | 277 | $94.8 |
| 2026-06-30 | WILLIAMS CHRISTOPHER J | — | Grant | A | $0 | 288 | $0.0 |
| 2026-06-30 | WEINER RUSSELL J | — | Grant | A | $0 | 354 | $0.0 |
| 2026-06-30 | Plaines Stephanie | — | Grant | A | $0 | 288 | $0.0 |
| 2026-06-30 | Shattock Matthew J | — | Grant | A | $0 | 550 | $0.0 |
| 2026-06-30 | Breber Pierre R | — | Grant | A | $0 | 354 | $0.0 |
| 2026-06-17 | Bellet Luc | EVP - Chief Financial Officer | Grant | A | $4.0M | 42,118 | $95.0 |
| 2026-06-17 | Hilt Angela C | EVP - Chief Legal Officer | Grant | A | $2.5M | 26,324 | $95.0 |
| 2026-06-17 | Marriner Kirsten | EVP - Chief Admin Officer | Grant | A | $2.5M | 26,324 | $95.0 |
| 2026-06-17 | Hyder Chris T | EVP-Chief Operating Officer | Grant | A | $4.0M | 42,118 | $95.0 |
| 2026-05-08 | WILLIAMS CHRISTOPHER J | — | Grant | A | $0 | 297 | $0.0 |
| 2026-05-08 | WEINER RUSSELL J | — | Grant | A | $0 | 242 | $0.0 |
| 2026-05-08 | Plaines Stephanie | — | Grant | A | $0 | 104 | $0.0 |
| 2026-05-08 | Shattock Matthew J | — | Grant | A | $0 | 271 | $0.0 |
| 2026-05-08 | Breber Pierre R | — | Grant | A | $0 | 42 | $0.0 |
| 2026-05-05 | Breber Pierre R | — | Buy | P | $429.1K | 5,000 | $85.8 |
| 2026-04-01 | Bellet Luc | EVP - Chief Financial Officer | Other | F | $25.3K | 244 | $103.6 |
| 2026-03-31 | WILLIAMS CHRISTOPHER J | — | Grant | A | $0 | 265 | $0.0 |
| 2026-03-31 | WEINER RUSSELL J | — | Grant | A | $0 | 326 | $0.0 |
| 2026-03-31 | Shattock Matthew J | — | Grant | A | $0 | 507 | $0.0 |
| 2026-03-31 | Breber Pierre R | — | Grant | A | $0 | 326 | $0.0 |
| 2026-03-31 | Plaines Stephanie | — | Grant | A | $0 | 265 | $0.0 |
| 2026-03-13 | Hyder Chris T | EVP-Group Pres -Hlth & Hyg | Grant | — | $4.5K | 41 | $108.7 |
| 2026-03-13 | Grier Stacey | EVP - Executive Chief of Staff | Grant | — | $3.5K | 32 | $108.7 |
| 2026-02-13 | WILLIAMS CHRISTOPHER J | — | Grant | A | $0 | 213 | $0.0 |
| 2026-02-13 | WEINER RUSSELL J | — | Grant | A | $0 | 172 | $0.0 |
| 2026-02-13 | Shattock Matthew J | — | Grant | A | $0 | 191 | $0.0 |
| 2026-02-13 | Breber Pierre R | — | Grant | A | $0 | 27 | $0.0 |
| 2026-02-13 | Plaines Stephanie | — | Grant | A | $0 | 73 | $0.0 |
| 2025-12-31 | WILLIAMS CHRISTOPHER J | — | Grant | — | $0 | 1,638 | $0.0 |
| 2025-12-31 | WILLIAMS CHRISTOPHER J | — | Grant | — | $0 | 273 | $0.0 |
| 2025-12-31 | WEINER RUSSELL J | — | Grant | — | $0 | 1,638 | $0.0 |
| 2025-12-31 | WEINER RUSSELL J | — | Grant | — | $0 | 335 | $0.0 |
| 2025-12-31 | Shattock Matthew J | — | Grant | — | $0 | 1,638 | $0.0 |
| 2025-12-31 | Shattock Matthew J | — | Grant | — | $0 | 521 | $0.0 |
| 2025-12-31 | Plaines Stephanie | — | Grant | — | $0 | 1,638 | $0.0 |
| 2025-12-31 | Plaines Stephanie | — | Grant | — | $0 | 273 | $0.0 |
| 2025-12-31 | MACKAY A D DAVID | — | Grant | — | $0 | 1,638 | $0.0 |
| 2025-12-31 | Lee Esther | — | Grant | — | $0 | 1,638 | $0.0 |
| 2025-12-31 | Fleischer Spencer C | — | Grant | — | $0 | 1,219 | $0.0 |
| 2025-12-31 | Fleischer Spencer C | — | Grant | — | $0 | 145 | $0.0 |
| 2025-12-31 | Charter Julia | — | Grant | — | $0 | 1,638 | $0.0 |
| 2025-12-31 | Breber Pierre R | — | Grant | — | $0 | 1,638 | $0.0 |
| 2025-12-31 | Breber Pierre R | — | Grant | — | $0 | 335 | $0.0 |
| 2025-12-31 | Bratspies Stephen B | — | Grant | — | $0 | 1,638 | $0.0 |
| 2025-12-31 | Boswell Gina | — | Grant | — | $0 | 825 | $0.0 |
| 2025-12-12 | Reynolds Eric H | EVP - Chief Operating Officer | Grant | — | $26.2K | 255 | $102.8 |
| 2025-12-12 | Rendle Linda J | Chief Executive Officer | Grant | — | $85.2K | 829 | $102.8 |
| 2025-12-12 | Peck Laurene E | VP - CAO & Corp Controller | Grant | — | $2.5K | 24 | $102.8 |
Showing the most recent 50 of 116 transactions. For the full 1-year history with sorting, filtering, and cross-ticker industry context, open the full insider transactions drilldown.
Top Insider Buyers of CLX By dollar volume, 1-year window
- Breber Pierre R $845.6K
Methodology & FAQ
How We Track CLX Insider Transactions
Form 4 disclosures are sourced directly from SEC EDGAR and re-ingested on every pipeline cycle. A complete description of transaction-code handling, the open-market vs grant distinction, and the Rule 10b5-1 plan-reference heuristic is documented in the Methodology.
What is an SEC Form 4 filing for CLOROX CO /DE/?
Form 4 is a transaction-level disclosure that corporate insiders — officers, directors, and beneficial owners of more than 10% of a registered class of equity securities — must file with the SEC within two business days of any change in their beneficial ownership of CLOROX CO /DE/ (CLX) shares.
What is a Rule 10b5-1 trading plan?
Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Form 4 rows marked "10b5-1" on this page indicate the underlying trade was executed under such a plan; rows without the badge are discretionary or did not reference a plan in the Form 4 footnotes.
How is "insider buying" different from a stock grant or option exercise?
An insider buy (SEC transaction code P) is an open-market purchase of CLOROX CO /DE/ (CLX) stock executed at the prevailing market price using the insider's personal capital. Stock grants (code A) and option exercises (code M) are compensation events, not directional trades; they are tracked separately and excluded from the "conviction" signal because they are not discretionary purchases.
How recent is the data?
Form 4 transactions are typically reported within two business days of execution. Pactolio re-ingests the EDGAR feed on a nightly cycle and reflects new filings on the next ingest run, typically within 24 hours of EDGAR acceptance. The table on this page covers the most recent 1-year window.